“I am a doctor who reveals idiots as a hobby,” says Ben Goldacre. If so, it’s become a pretty comprehensive hobby.
Some medical research data never get published because they don’t fit in with the pharmaceutical industry’s desired results. Profiled researcher and social commentator Ben Goldacre will shed some light on this very topic when he takes part in NTNU’s The Big Challenge science festival in Trondheim in June.
The discharge of pharmaceutical drugs is a major problem around the world, but a new study of the freshwater fish burbot shows that there is hope.
The higher a person’s BMI, the greater the chance of getting psoriasis. But researchers are still uncertain as to why.
Metformin significantly reduces the risk of late miscarriages and preterm births for women with PCOS. But the drug does not work to prevent gestational diabetes, according to a large Nordic study from NTNU and St. Olavs hospital.
Some pregnant women are so conflicted about abortion that they don’t even talk about it with their own mother.
An enzyme that normally repairs damaged DNA may be the key to a new treatment for inflammatory diseases.
Back in the 1970s, a Norwegian family was found to have abnormally high red blood cell counts. Thirty-five years later, researchers succeeded in solving the mystery, thanks to new analytical methods and the latest developments in genetic engineering – and a chance meeting with a Swiss scientist.
Only a small percentage of medical students become full-time researchers. But university research tracks have increased the proportion of doctoral degrees taken tenfold.
No, this question isn’t only for people who’ve smoked a lot. Seven factors, including two new ones, can predict whether you have a high risk of developing lung cancer.
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming. Testing existing anti-viral drugs for their ability to combat multiple viral infections can help.
Every day people are whisked into Norwegian hospital emergency rooms with concussions. A new study shows that even mild head trauma can cause major problems in daily life.
A treatment that kills the cancer cells in one fell swoop, without causing the patient to feel sick from the medication’s side effects? That’s the goal of new personalized cancer therapies that are being developed across the globe, including at NTNU.
Organizational downsizing and job loss greatly increase a person’s risk of having to start different medications. Prescriptions for drugs to treat mental health issues are particularly widespread in this group.
A new approach to cancer treatment combines ultrasound, bubbles and nanoparticles with chemotherapy. In an experiment, the treatment has cured cancer in mice.
What is the best form of first aid for a cold, injured body? Mountain medicine researchers are now co-operating to find the answer. At present there is actually no “best practice” for treating this type of patients.
Surgeons often take a blood vessel from your leg to graft onto your heart during a coronary bypass surgery. The practice can lead to scarring in many patients, which in turn can cause another heart attack. A new technique under development may help prevent this problem.
People with cystic fibrosis (CF) need help to ensure they are getting correct nutrition and the right amount of enzymes. They also need constant reminders. Researchers are now developing a digital support device to promote autonomy, but are finding that this is no easy task.
Sepsis, commonly called blood poisoning, is a common affliction that can affect people of all ages. A series of simple measures tested at a Norwegian hospital can make a difference in successfully treating sepsis.
Researchers are now working to design stable micro-bubbles which, combined with ultrasound, can deliver cancer drugs straight to the target tumour.
Ebola’s deadly effects on the Sierra Leonean healthcare community not only has repercussions for the delivery of health care now, but on the training of future health care providers involved in an innovative Norwegian surgical training programme.